These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33351968)

  • 1. Clinicopathological and molecular characterisation of papillary renal neoplasm with reverse polarity and its renal papillary adenoma analogue.
    Chang HY; Hang JF; Wu CY; Lin TP; Chung HJ; Chang YH; Pan CC
    Histopathology; 2021 Jun; 78(7):1019-1031. PubMed ID: 33351968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent KRAS mutations identified in papillary renal neoplasm with reverse polarity-a comparative study with papillary renal cell carcinoma.
    Kim SS; Cho YM; Kim GH; Kee KH; Kim HS; Kim KM; Kim JH; Choi C
    Mod Pathol; 2020 Apr; 33(4):690-699. PubMed ID: 31953522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological, immunohistochemical, and genomic analyses of papillary renal neoplasm with reverse polarity.
    Kiyozawa D; Kohashi K; Takamatsu D; Yamamoto T; Eto M; Iwasaki T; Motoshita J; Shimokama T; Kinjo M; Oshiro Y; Yonemasu H; Oda Y
    Hum Pathol; 2021 Jun; 112():48-58. PubMed ID: 33811832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Papillary renal neoplasm with reverse polarity-a comparative study with CCPRCC, OPRCC, and PRCC1.
    Wang T; Ding X; Huang X; Ye J; Li H; Cao S; Gao Y; Ma X; Huang Q; Wang B
    Hum Pathol; 2022 Nov; 129():60-70. PubMed ID: 35977593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Papillary renal neoplasm with reverse polarity with a favorable prognosis should be separated from papillary renal cell carcinoma.
    Liu Y; Zhang H; Li X; Wang S; Zhang Y; Zhang X; Xu T; Dong Y; Dong L; Zhou L; Yang X; Wang C
    Hum Pathol; 2022 Sep; 127():78-85. PubMed ID: 35724772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papillary renal neoplasm with reverse polarity: a clinicopathologic study of 43 cases with a focus on the expression of KRAS signaling pathway downstream effectors.
    Kim B; Lee S; Moon KC
    Hum Pathol; 2023 Dec; 142():1-6. PubMed ID: 37797754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent KRAS mutations in oncocytic papillary renal neoplasm with inverted nuclei.
    Tong K; Zhu W; Fu H; Cao F; Wang S; Zhou W; Liu C; Chen D; Fan S; Hu Z
    Histopathology; 2020 Jun; 76(7):1070-1083. PubMed ID: 31997427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-coding RNA and gene expression analyses of papillary renal neoplasm with reverse polarity (PRNRP) reveal distinct pathological mechanisms from other renal neoplasms.
    Nemours S; Armesto M; Arestín M; Manini C; Giustetto D; Sperga M; Pivovarcikova K; Pérez-Montiel D; Hes O; Michal M; López JI; Lawrie CH
    Pathology; 2024 Jun; 56(4):493-503. PubMed ID: 38413252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Papillary Renal Neoplasm With Reverse Polarity: A Clinical, Pathologic, and Molecular Study of 8 Renal Tumors From a Single Institution.
    Nova-Camacho LM; Martin-Arruti M; Díaz IR; Panizo-Santos Á
    Arch Pathol Lab Med; 2023 Jun; 147(6):692-700. PubMed ID: 36170616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillary Renal Neoplasm With Reverse Polarity Is Often Cystic: Report of 7 Cases and Review of 93 Cases in the Literature.
    Wei S; Kutikov A; Patchefsky AS; Flieder DB; Talarchek JN; Al-Saleem T; Dulaimi E; Uzzo RG; Testa JR; Pei J
    Am J Surg Pathol; 2022 Mar; 46(3):336-343. PubMed ID: 34352808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Papillary renal neoplasm with reverse polarity: a clinicopathological analysis].
    Ji RH; Wang XT; Li R; Ye SB; Wang X; Ma HH; Lu ZF; Rao Q; Xia QY
    Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):23-27. PubMed ID: 34979749
    [No Abstract]   [Full Text] [Related]  

  • 12. Papillary renal neoplasm with reverse polarity: A clinicopathological and molecular genetic characterization of 16 cases with expanding the morphologic spectrum and further support for a novel entity.
    Shen M; Yin X; Bai Y; Zhang H; Ru G; He X; Teng X; Chen G; Zhao M
    Front Oncol; 2022; 12():930296. PubMed ID: 35936734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unilateral synchronous papillary renal neoplasm with reverse polarity and clear cell renal cell carcinoma: a case report with KRAS and PIK3CA mutations.
    Lee HJ; Shin DH; Park JY; Kim SY; Hwang CS; Lee JH; Kim JY; Sol MY; Nam JK
    Diagn Pathol; 2020 Oct; 15(1):123. PubMed ID: 33023600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarity.
    Al-Obaidy KI; Saleeb RM; Trpkov K; Williamson SR; Sangoi AR; Nassiri M; Hes O; Montironi R; Cimadamore A; Acosta AM; Alruwaii ZI; Alkashash A; Hassan O; Gupta N; Osunkoya AO; Sen JD; Baldrige LA; Sakr WA; Idrees MT; Eble JN; Grignon DJ; Cheng L
    Mod Pathol; 2022 Sep; 35(9):1279-1286. PubMed ID: 35152262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papillary renal neoplasm with reverse polarity: an observational study of histology, immunophenotypes, and molecular variation.
    Han H; Yin SY; Song RX; Zhao J; Yu YW; He MX; Wang H
    Transl Androl Urol; 2024 Mar; 13(3):383-396. PubMed ID: 38590969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Papillary renal neoplasm with reverse polarity may be a novel renal cell tumor entity with low malignant potential.
    Yang T; Kang E; Zhang L; Zhuang J; Li Y; Jiang Y; Wang H; Yu W; Zhang W
    Diagn Pathol; 2022 Aug; 17(1):66. PubMed ID: 36002896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent KRAS mutations in papillary renal neoplasm with reverse polarity.
    Al-Obaidy KI; Eble JN; Nassiri M; Cheng L; Eldomery MK; Williamson SR; Sakr WA; Gupta N; Hassan O; Idrees MT; Grignon DJ
    Mod Pathol; 2020 Jun; 33(6):1157-1164. PubMed ID: 31534204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated Molecular Analysis of Papillary Renal Cell Carcinoma and Precursor Lesions Unfolds Evolutionary Process from Kidney Progenitor-Like Cells.
    Saleeb RM; Farag M; Ding Q; Downes M; Bjarnason G; Brimo F; Plant P; Rotondo F; Lichner Z; Finelli A; Yousef GM
    Am J Pathol; 2019 Oct; 189(10):2046-2060. PubMed ID: 31381885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papillary Renal Cell Carcinoma With Microcystic Architecture Is Strongly Associated With Extrarenal Invasion and Metastatic Disease.
    Chan E; Stohr BA; Butler RS; Cox RM; Myles JL; Nguyen JK; Przybycin CG; Reynolds JP; Williamson SR; McKenney JK
    Am J Surg Pathol; 2022 Mar; 46(3):392-403. PubMed ID: 34881751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal papillary adenoma--a putative precursor of papillary renal cell carcinoma.
    Wang KL; Weinrach DM; Luan C; Han M; Lin F; Teh BT; Yang XJ
    Hum Pathol; 2007 Feb; 38(2):239-46. PubMed ID: 17056094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.